PODCAST · education
Heart Rhythm TV Pod
by Heart Rhythm TV
Welcome to the Heart Rhythm TV Pod — your go-to source for the latest in cardiac electrophysiology. As the official news and media outlet of the Heart Rhythm Society (HRS), Heart Rhythm TV (HRStv) brings you expert insights, breaking news, and in-depth coverage of major events like the annual Heart Rhythm meeting and the innovation-focused HRX meeting. With a global audience spanning 98 countries on YouTube, we're now bringing the conversation to your favorite podcast platform—anytime, anywhere.
-
171
Episode 170: Final Results of the LEADR LBBAP clinical trial
Recorded at #HRS2026 in Chicago, #HRStv host Oliver J. Monfredi, MBChB, PhD, FHRS, is joined by Pugazhendhi Vijayaraman, MD, FHRS, to discuss Longer-term safety and LOT-CRT functional outcomes using a novel, small-diameter defibrillation lead: Final Results of the LEADR LBBAP clinical trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
170
Episode 169: CIED Lead Management in 2026 - What's Changed and How It Impacts Practice
Mikhael F. El-Chami, MD, FHRS, talks with Yong-Mei Cha, MD, FHRS, and Christopher F. Liu, MD, FHRS, authors of "2026 HRS/AHA/APHRS/EHRA/IDSA/LAHRS/PACES/STS expert consensus statement update on cardiovascular implantable electronic device lead management and extraction", which published in the April 2026 issue of Heart Rhythm. Additional Resources https://www.heartrhythmjournal.com/article/S1547-5271(26)02264-2/fulltext Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
169
Episode 168: 2026 ACC/AHA/HRS Advanced Training Statement on Clinical Cardiac EP
Mehak Dhande, MD, MS, talks with Jose A. Joglar, MD, FHRS, author of "2026 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology (Revision of the 2015 ACC/AHA/HRS advanced training statement on clinical cardiac electrophysiology)", which published in the April 2026 issue of Heart Rhythm. Additional Resources https://www.heartrhythmjournal.com/article/S1547-5271(26)02116-8/fulltext Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
168
Episode 167: Subthreshold broadband stimulation restores intrinsic sinoatrial pacemaker cell activity (HRS 2026)
Recorded at #HRS2026 in Chicago, #HRStv host Oliver J. Monfredi, MBChB, PhD, FHRS, is joined by Isabella He, to discuss Beyond electronic pacing: subthreshold broadband stimulation restores intrinsic sinoatrial pacemaker cell activity. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
167
Episode 166: Long term effect on coronary artery after pulsed field ablation (HRS 2026)
Recorded at #HRS2026 in Chicago, #HRStv host Mehak Dhande, MD, MS, is joined by Mark TK Tam, MBChB, to discuss Long term effect on coronary artery after pulsed field ablation - a serial OCT study with extended follow-up. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
166
Episode 165: Results of the ASCEND EV Pilot Study (HRS 2026)
Recorded at #HRS2026 in Chicago, #HRStv host Oliver J. Monfredi, MBChB, PhD, FHRS, is joined by Paul A. Friedman, MD, FHRS, to discuss Six-Month Outcomes with a Novel Parasternal Extravascular ICD (EV-ICD) Lead: Results of the ASCEND EV Pilot Study. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
165
Episode 164: A Matter of Concern? The TiFFANY Study (HRS 2026)
Recorded at #HRS2026 in Chicago, #HRStv host Nashwa Abdulsalam, MBBS, is joined by Roland R. Tilz, MD, FHRS, to discuss Total Fatal Adverse Events Following Atrial Fibrillation Ablation Reported in an FDA Mandatory Reporting System: A Matter of Concern? The TiFFANY Study Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
164
Episode 163: ELEVATE PF - A First-In-Human Trial of a Novel Large Focal Map-And-Ablate PFA Catheter (HRS 2026)
Recorded at #HRS2026 in Chicago, #HRStv host Jeanne du Fay de Lavallaz, MD, is joined by Vivek Y. Reddy, MD, to discuss ELEVATE PF: A First-In-Human Trial of a Novel Large Focal Map-And-Ablate PFA Catheter. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
163
Episode 162: Ventricular Intramyocardial Navigation and Tachycardia Ablation Guided by Electrograms (VINTAGE): First-in-Human Experience with a Novel Therapy for Refractory Ventricular Arrhythmias - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Nashwa Abdulsalam, MBBS, sat down with Neal K. Bhatia, MD, to discuss Ventricular Intramyocardial Navigation and Tachycardia Ablation Guided by Electrograms (VINTAGE): First-in-Human Experience with a Novel Therapy for Refractory Ventricular Arrhythmias. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
162
Episode 161: #HRS2026 Day 4 Wrap Up
And just like that — #HRS2026 is officially a wrap! For our final day, we're looking back at an incredible HRS Gala, celebrating community at the President's Social, and highlighting the remaining late-breaking science that kept us on the edge of our seats through the very last session. Four days of connection, discovery, and moments we won't forget. We hope you walked away inspired, energized, and ready for what's next — because we sure did. Until next year — see you in San Francisco for #HRS2027! Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
161
Episode 160: #HRS2026 Day 3 Wrap Up
Another packed day and we're breaking it ALL down! More late-breaking science and high-impact science you need to know about, the annual passing of the torch to our new President-elect — plus so much more. Stay informed. Stay ahead. This is your Day 3 wrap-up. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
160
Episode 159: #HRS2026 Day 2 Wrap Up
Day 2 of #HRS2026 delivered! Dr. Glaucomflecken kicked things off right at the Opening Plenary — and the buzz hasn't stopped since. Late-Breaking Clinical Trials are in full swing, and Chicago is not letting us down. Watch the full wrap-up above and stay tuned to #HRStv for more coverage all week. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
159
Episode 158: #HRS2026 Day 1 Wrap Up
Day 1 of #HRS2026 did not disappoint! 🔥 Our #HRStv crew was on the ground for every moment — from the PFA Live Case Summit and the Global Summit on Sports, Exercise, and Medicine, to the incredible History of EP museum and so much more. Missed the action? We've got you covered with the full Day 1 rundown. Don't forget to subscribe and hit the 🔔 so you never miss a moment from #HRS2026! Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
158
Episode 157: The Landscape of ASCs in EP - Safety, Quality and Physician Alignment
#HRStv host Mehak Dhande is joined by Joseph E. Marine, MBA, MD, FHRS, and Roderick Tung, MD, FHRS, for an in-depth look at the growing landscape of Ambulatory Surgery Centers in Electrophysiology. From safety and quality benchmarks to the critical question of physician alignment — this conversation covers what's shaping the future of EP care outside the hospital setting. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
157
Episode 156: Long-term outcomes after left atrial appendage closure in anticoagulation-ineligible atrial fibrillation Patients: The Randomized ASAP-TOO Clinical Trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Deepthy Varghese, DNP, ACNP, FNP, sat down with Vivek Y. Reddy, MD, to discuss Long-term outcomes after left atrial appendage closure in anticoagulation-ineligible atrial fibrillation Patients: The Randomized ASAP-TOO Clinical Trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
156
Episode 154: Proton beam cardiac radioablation for refractory ventricular tachycardia: results from a first-in-human, prospective, non-randomized trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Deepthy Varghese, DNP, ACNP, FNP, sat down with Konstantinos C. Siontis, MD, FHRS, to discuss Proton beam cardiac radioablation for refractory ventricular tachycardia: results from a first-in-human, prospective, non-randomized trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
155
Episode 155: Outcomes of Left Atrial Appendage Closure vs Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-analysis of the CHAMPION-AF Clinical Trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host JC Zerpa Acosta, MD, FHRS, sat down with Kenneth Ellebogen, MD, FHRS, to discuss Outcomes of Left Atrial Appendage Closure vs Oral Anticoagulation in Patients with Atrial Fibrillation and Prior Ablation: A Sub-analysis of the CHAMPION-AF Clinical Trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
154
Episode 153: Early U.S. Experience with Catheter Ablation of Ventricular Arrhythmias with a Dual-Energy Lattice-Tip Catheter - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host JC Zerpa Acosta, MD, FHRS, sat down with Osama Dasa, MD, MPH, PhD, to discuss Early U.S. Experience with Catheter Ablation of Ventricular Arrhythmias with a Dual-Energy Lattice-Tip Catheter. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
153
Episode 152: Catheter Ablation versus Anti-arrhythmic Drugs for Ventricular Tachycardia in Ischaemic and Non-ischaemic cardiomyopathy: results from the CAAD-VT multi-centre randomized controlled trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host JC Zerpa Acosta, MD, FHRS, sat down with Saurabh Kumar, MD, PhD, FHRS, to discuss Catheter Ablation versus Anti-arrhythmic Drugs for Ventricular Tachycardia in Ischaemic and Non-ischaemic cardiomyopathy: results from the CAAD-VT multi-centre randomized controlled trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
152
Episode 151: One-year Outcomes of Nanosecond Pulse Field Ablation Using A Compliant Circular Catheter To Treat Atrial Fibrillation: A Multicenter Experience - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Oliver J. Monfredi, MBChB, PhD, FHRS, sat down with Vivek Y. Reddy, MD, to discuss One-year Outcomes of Nanosecond Pulse Field Ablation Using A Compliant Circular Catheter To Treat Atrial Fibrillation: A Multicenter Experience. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
151
Episode 150: Safety and Effectiveness of a Dual-Energy Focal Ablation Catheter to Treat Paroxysmal Atrial Fibrillation: 6-Month Results of the FlexPulse IDE Study - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Daniel M. Alyesh, MD, FHRS, sat down with Jonathan P. Piccini, Sr., MD, MHS, FHRS, to discuss Safety and Effectiveness of a Dual-Energy Focal Ablation Catheter to Treat Paroxysmal Atrial Fibrillation: 6-Month Results of the FlexPulse IDE Study. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
150
Episode 148: Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation (AVANT GUARD) - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Nashwa Abdulsalam, MBBS, sat down with Oussama M. Wazni, MD, FHRS, to discuss A Prospective Randomized Multicenter Global Study Comparing Pulsed Field Ablation versus Anti-Arrhythmic Drug Therapy as a First Line Treatment for Persistent Atrial Fibrillation (AVANT GUARD). Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
149
Episode 149: Six-Month Outcomes from the Sphere-9 Ventricular Tachycardia Early Feasibility Study: Dual-Energy Lattice-Tip Mapping and Ablation Catheter for Ventricular Tachycardia Treatment - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Daniel M. Alyesh, MD, FHRS, sat down with Vivek Y. Reddy, MD, to discuss Six-Month Outcomes from the Sphere-9 Ventricular Tachycardia Early Feasibility Study: Dual-Energy Lattice-Tip Mapping and Ablation Catheter for Ventricular Tachycardia Treatment. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
148
Episode 147: Real-World Experience with the Extravascular ICD through One Year from the Enlighten Post-Approval Registry Study - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Deepthy Varghese, DNP, ACNP, FNP, sat down with Lucas V. A. Boersma, MD, PhD, to discuss Real-World Experience with the Extravascular ICD through One Year from the Enlighten Post-Approval Registry Study. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
147
Episode 146: Safety and Efficacy of a Novel ICD Lead for Left Bundle Branch Area Pacing: Results from the ASCEND CSP Trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Nashwa Abdulsalam, MBBS, sat down with Robert D Schaller, DO, FHRS, to discuss Safety and Efficacy of a Novel ICD Lead for Left Bundle Branch Area Pacing: Results from the ASCEND CSP Trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
146
Episode 145: LEAP2: A First-In-Human Study of a Chronically-Implanted Novel Leadless Pacemaker for Conduction System Pacing - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host JC Zerpa Acosta, MD, FHRS, sat down with Vivek Y. Reddy, MD, to discuss LEAP2: A First-In-Human Study of a Chronically-Implanted Novel Leadless Pacemaker for Conduction System Pacing. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
145
Episode 144: The primary results of the PRAETORIAN-DFT Trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Oliver J. Monfredi, MBChB, PhD, FHRS, sat down with Reinoud Knops, MD, PhD, FHRS, to discuss A randomized comparison of subcutaneous implantable cardioverter-defibrillator implantation with or without defibrillation testing: the primary results of the PRAETORIAN-DFT Trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
144
Episode 143: Variable Loop Circular Catheter Pulsed Field Ablation in Real-World Practice - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Ambrose F. Panico, DO, sat down with Christopher P. Porterfield, MD, MPH, PhD, FHRS, to discuss Variable Loop Circular Catheter Pulsed Field Ablation in Real-World Practice: Low Complication Rates Across Patient and Procedural Characteristics. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
143
Episode 142: A Substudy of the ALONE-AF Trial - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Daniel M. Alyesh, MD, FHRS, sat down with Boyoung Joung, MD, PhD, FHRS, to discuss Cognitive Function and Anticoagulation Discontinuation in Patients Without Long-Term Recurrence After Catheter Ablation for Atrial Fibrillation: A Substudy of the ALONE-AF Trial. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
142
Episode 141: Primary Results of the COMPASS HRS Quality Improvement Initiative - #HRS2026 LBCT
Immediately following the #LBCT presentation at #HRS2026, Heart Rhythm TV host Mehak Dhande, MD, MS, sat down with Sean D. Pokorney, MBA, MD, and Roopinder K. Sandhu, MD, MPH, FHRS, to discuss Centers of Excellence Optimal Management Pathways for Atrial Fibrillation Specialty Services Early Rhythm Control Treatment Care Pathway: Primary Results of the COMPASS Heart Rhythm Society Quality Improvement Initiative. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
141
Episode 140: BEAT PERS AF, a randomised comparison of PFA vs RFA - #EHRA2026 LBCT
In this #EHRA2026 Update, Suneet Mittal, MD, FHRS, is joined by Pierre Jais, MD, to discuss the BEAT PERS AF trial — a randomised comparison of Pulsed Field Ablation versus Radiofrequency Ablation in persistent atrial fibrillation. Get the trial results, expert analysis, and what this means for the future of AF ablation. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
140
Episode 139: When to Stop Anticoagulation after successful PVI? - #EHRA2026 LBCT
In this #EHRA2026 Update, Suneet Mittal, MD, FHRS, is joined by Andre Rodrigues Pontes Briosa e Gala, MD, CCDS, discussing the validation of the OCEAN/ALONE-AF criteria using continuous rhythm monitoring — and what it means for your patients. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
139
Episode 138: PERFECT-PAF: PFA versus CRYO for Paroxysmal AF - #EHRA2026 LBCT
In this #EHRA2026 Update, Suneet Mittal, MD, FHRS, is joined by Gian Battista Chierchia, MD, PhD, to break down the PERFECT-PAF trial — a head-to-head comparison of PFA versus Cryo for Paroxysmal AFib. Tune in for key findings, clinical implications, and expert insights. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
138
Episode 137: Controversies in EP: GLP-1 Agonists - Hype, Help, or Here to Stay?
In this episode of Controversies in EP, #HRStv host Nashwa Abdulsalam, MBBS, sits down with Nicolette Bembenek, MD, to unpack the GLP-1 agonist boom. Together, they discuss the science behind how GLP-1s work, their expanding role beyond diabetes and obesity, and the critical misconceptions that even experienced clinicians get wrong. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
137
Episode 136: ACC 2026 - The CHAMPION AF Trial
In this Breaking News update, #HRStv host Daniel Alyesh, MD, FHRS, is joined by Shephal K. Doshi, MD, to discuss the late breaking clinical trial CHAMPION-AF at ACC 2026, a prospective, randomized, multi-center non inferiority trial seeking to understand LAAO as an alternative to DOACs. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
136
Episode 135: ICE Image of the Month - PFA and VT Ablation (Part II)
In this episode of ICE Image of the Month, #HRStv host Daniel M. Alyesh, MD, FHRS is joined by Konstantinos C. Siontis, MD, FHRS to review a case report of the first in human application of colocalized PF and RF using the dual energy STSF with ICE guidance. They discuss procedural, anatomic, and biophysical concepts. Additional Resources Patil, S., Siontis, K.C. First-in-human use of the dual-energy SMARTTOUCH™ SF radiofrequency and pulsed field ablation catheter for ventricular arrhythmia treatment. J Interv Card Electrophysiol (2026). https://doi.org/10.1007/s10840-025-02219-0 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
135
Episode 134: Obesity, GLP 1s, and the Missing Link in AFib Care
In this Controversies in EP episode, #HRStv host Nashwa Abdulsalam, MBBS, is joined by Nicolette Bembenek, MD, to discuss a key gap in managing AFib. While electrophysiologists are comfortable prescribing antiarrhythmic drugs and performing ablations, there's often no clear plan when it comes to addressing weight management. In this discussion, they explore the complex risk factors behind obesity, how it impacts AFib care, and where emerging therapies like GLP-1 receptor agonists may fit into the conversation. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
134
Episode 133: Understanding Postural Orthostatic Tachycardia Syndrome
In this episode of Advancing Allieds, #HRStv host Deepthy Varghese is joined by Lauren Sell, MSN, APRN, CPNP, and Margo Walton, MSN, AGPCNP-BC, CHFN, to break down Postural Orthostatic Tachycardia Syndrome (POTS). They review diagnostic criteria, pathophysiology, and common symptoms, with a focused discussion on tilt table testing—its role and limitations. The episode also highlights POTS subtypes, treatment strategies (both non-pharmacologic and pharmacologic), and key differential diagnoses, including Inappropriate Sinus Tachycardia. A practical, clinically focused conversation designed to support allied professionals in improving diagnostic accuracy and patient care. Additional Resources https://www.youtube.com/watch?v=iqWXChgKtCc https://pmc.ncbi.nlm.nih.gov/articles/PMC5267948/ Usefulness of Tilt Testing in Children with Syncope: A Survey of Pediatric Electrophysiologists – PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC11571393/ https://www.dysautonomiainternational.org/pdf/CHOP_Modified_Dallas_POTS_Exercise_Program.pdf https://www.jimharrismd.com/articles/exercise-for-pots-chop-protocol-dallas-protocol-and-levine-protocol Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
133
Episode 132: Early Outcomes of the VERITAS Study and Amulet 360
In this Breaking News update, #HRStv host Daniel M. Alyesh, MD, FHRS, and Devi G. Nair, MD, FHRS, discuss the early outcomes of the Amulet 360 left atrial appendage occlusion device as presented at the 2026 AF Symposium as part of the pre-clinical VERITAS study. Additional Resources Nair, D, Freixa, X, Ellis, C. et al. Early Outcomes With a Next-Generation Dual-Seal Left Atrial Appendage Occluder: Results From the VERITAS Study. J Am Coll Cardiol EP. null2026, 0 (0). Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
132
Episode 131: Unlocking Antiarrhythmics From ABCs to Action — Next-Gen Rhythm Monitoring at Home
In Episode 3 of Unlocking Antiarrhythmics From ABCs to Action, #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Megan Labreck, PharmD, Jose L. Merino, MD, PhD, and Rachel Schreier, MSN, ACNP, APRN, to explore the cutting-edge intersection of wearable technology and antiarrhythmic drugs (AADs) in managing heart rhythm conditions from home. Discover how next-generation wearables are making continuous arrhythmia monitoring possible — delivering real-time data that helps guide treatment decisions and improve patient outcomes. We break down how these devices work alongside AAD therapy, highlight the latest innovations in remote cardiac monitoring, and share practical insights on integrating technology into everyday care. Additional Resources https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.10.003 https://www.heartrhythmopen.com/article/S2666-5018(24)00147-8/fulltext https://www.jacc.org/doi/10.1016/j.jacep.2022.11.026 https://academic.oup.com/europace/article/27/8/euaf076/8100306?login=true https://www.jacc.org/doi/10.1016/j.jacep.2022.09.011 https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1172666/full Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
131
Episode 130: Results from the I-CLAS Study - a Journal Club in Collaboration with CardioNerds
In this episode of CardioNerds Journal Club, Naima Maqsood, MBBS, and Sukriti Banthiya, MD, are joined by Pugazhendhi Vijayaraman, MD, FHRS, and Theofanie Mela, MD, to break down results from the I-CLAS Study — a timely investigation exploring new insights into atrial fibrillation management and outcomes across diverse patient populations. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
130
Episode 129: A Sneak Peek at Heart Rhythm 2026 - Must See Science, Sessions & Community
Heart Rhythm 2026 is shaping up to be one of the most exciting programs we've ever assembled, bringing the global electrophysiology community together for four days of groundbreaking science, education, and connection. Join us in Chicago at McCormick Place, April 23–26, 2026, for more than 200 expert-led sessions, late-breaking clinical trials, hands-on learning, Hyde Park debates, abstract presentations, and the latest innovations in the Exhibit Hall. Highlights include Global Summit 2026, Friday's Opening Plenary featuring keynote speaker Dr. Glaucomflecken, the return of the Heart Rhythm Bowl, and enhanced programming through Sunday afternoon. Heart Rhythm 2026 is more than a meeting — it's where the EP community comes together to shape what's next for the field and improve outcomes for patients worldwide. Learn more and register here: https://bit.ly/3NRagMP Early-bird rates are available through February 10.
-
129
Episode 128: HRCR Spotlight - Interview with Rahul Doshi, MD, FHRS, New Editor-in-Chief, Heart Rhythm Case Reports
Rahul Doshi, MD, FHRS, the new Editor-in-Chief of Heart Rhythm Case Reports (#HRCR), sits down with HRCR's new Heart Rhythm TV Correspondent Daniel Alyesh, MD, FHRS to discuss his vision for "the people's journal," including its new partnership with #HRStv. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
128
Episode 127: Unlocking Antiarrhythmics From ABCs to Action — Real-World Rhythm-Personalizing AADs Across Populations
In Episode 2 of Unlocking Antiarrhythmics From ABCs to Action, #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Jose L. Merino, MD, PhD to explore what it means to truly personalize antiarrhythmic drug (AAD) therapy across diverse patient populations. Together, they discuss real-world strategies for tailoring treatment based on age, comorbidities, arrhythmia type, and individual risk factors — highlighting how precision medicine is reshaping rhythm management. From dosing considerations to emerging research and clinical challenges, viewers will gain actionable insight to help optimize AAD use in varied care settings and deliver more confident, patient-centered treatment. Stay tuned for Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home Additional Resources https://academic.oup.com/europace/article/27/8/euaf076/8100306?login=true https://www.jacc.org/doi/10.1016/j.jacep.2024.11.020 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
127
Episode 126: PFA and Delayed Myocardial Ischemia and Malignant Arrhythmias
In this Breaking News conversation, #HRStv host Daniel M. Alyesh, MD, FHRS, is joined by Melanie Gunawardene, MD, FHRS, and Julian Chun, MD, to discuss a recent Circulation Research Letter describing life-threatening delayed myocardial ischemia and arrhythmias following PFA for AFib. They explore the proposed mechanisms and its correlation with the MANIFEST US study, as well as comparisons with thermal ablation data. Additional Resources Circulation. 2026;153:00–00. DOI: 10.1161/CIRCULATIONAHA.125.077983 Turagam, M, Aryana, A, Day, J. et al. Multicenter Study on the Safety of Pulsed Field Ablation in Over 40,000 Patients: MANIFEST-US. JACC. null2025, 0 (0) Circ Arrhythm Electrophysiol. 2023;16:e011365. DOI: 10.1161/CIRCEP.122.011365 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
126
Episode 125: Unlocking Antiarrhythmics From ABCs to Action — Foundations First: AAD Classes & Safety
Unlocking Antiarrhythmics From ABCs to Action is a new 3-part series designed to strengthen foundational knowledge and support real-world clinical decision-making for allied professionals. From the basics to advanced strategies, this episode breaks down antiarrhythmic drug classes, safety considerations, and how to personalize therapy across diverse patient populations — including the latest on outpatient sotalol and wearable heart monitoring. #HRStv host Deepthy Varghese, DNP, ACNP, FNP is joined by Megan Labreck, PharmD, and Rachel Schreier, MSN, ACNP, APRN for a practical, clinically focused discussion to support confident patient care. Stay tuned for Episodes 2 and 3: Episode 2: Real-World Rhythm — Personalizing AADs Across Populations Episode 3: Wearables and AADs: Next-Gen Rhythm Monitoring at Home Additional Resources https://academic.oup.com/europace/advance-article/doi/10.1093/europace/euaf076/8100306 https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.11.020 https://www.jacc.org/doi/abs/10.1016/j.jacep.2024.10.003 https://www.sciencedirect.com/science/article/pii/S2666501824001478 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
125
Episode 124: Ablation in ASCs 2026
Roderick Tung, MD, FHRS, talks with Amit J. Shanker, MD, FHRS, author of "HRS/ACC scientific statement: Guiding principles on the performance of intracardiac ablation procedures in ambulatory surgical centers", which published in the January 2026 issue of Heart Rhythm. Additional Resources Article: https://www.heartrhythmjournal.com/article/S1547-5271(25)02874-7/fulltext Issue: https://www.heartrhythmjournal.com/issue/S1547-5271(25)X0013-8 Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
124
Episode 123: Cardiac Contractility Modulation Therapy in 2025
In this episode of Left to Our Own Devices, #HRStv host Oliver J. Monfredi, MBChB, PhD, FHRS is joined by Jurgen Kuschyk, MD, PhD for a clinician-focused introduction to CCM therapy, highlighting key developments, evolving indications, and practical considerations based on 2025 clinical insights and experience. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
123
Episode 122: Heart Rhythm Society to Develop PFA Data Collection Platform
The Heart Rhythm Society announced plans to develop a first-of-its-kind Pulsed Field Ablation data collection platform (registry), sponsored in part by Johnson & Johnson MedTech, a global leader in the treatment of heart rhythm disorders. The platform will offer a national, technology-enabled infrastructure designed to advance clinical evidence, improve patient outcomes, and support post-market surveillance for atrial fibrillation PFA procedures. Read the full press release here: https://bit.ly/4qijiQQ Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
-
122
Episode 121: Expert Insights on PFA in China
In this new Global EP episode, Prashanthan Sanders, MBBS, PhD, FHRS is joined by Minglong Chen, MD, PhD to highlight exciting developments on PFA in China. Want to explore more content? Catch the full video versions and more on our channel – [Heart Rhythm TV].
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Welcome to the Heart Rhythm TV Pod — your go-to source for the latest in cardiac electrophysiology. As the official news and media outlet of the Heart Rhythm Society (HRS), Heart Rhythm TV (HRStv) brings you expert insights, breaking news, and in-depth coverage of major events like the annual Heart Rhythm meeting and the innovation-focused HRX meeting. With a global audience spanning 98 countries on YouTube, we're now bringing the conversation to your favorite podcast platform—anytime, anywhere.
HOSTED BY
Heart Rhythm TV
CATEGORIES
Loading similar podcasts...